Darja Žontar

CD56 Expression Is an Important Prognostic Factor in Multiple Myeloma Even with Bortezomib Induction

Matevž Škerget, Barbara Skopec, Vesna Zadnik et al. · Acta Haematologica · 2018 · 35 citations

Medicine, Hematology, Oncology +17

Intra‐ and interlaboratory variability of paroxysmal nocturnal hemoglobinuria testing by flow cytometry following the 2012 Practical Guidelines for high‐sensitivity paroxysmal nocturnal hemoglobinuria testing

Iuri Marinov, Martina Kohoutová, Vlasta Tkáčová et al. · Cytometry Part B Clinical Cytometry · 2013 · 28 citations · Full text

Medicine, Hematology, Hematology Physiology +12

RUNX1 amplification in lineage conversion of childhood B-cell acute lymphoblastic leukemia to acute myelogenous leukemia

Helena Podgornik, Maruša Debeljak, Darja Žontar et al. · Cancer Genetics and Cytogenetics · 2007 · 11 citations

Medicine, Genetics, Oncology +17

Mobilization with cyclophosphamide reduces the number of lymphocyte subpopulations in the leukapheresis product and delays their reconstitution after autologous hematopoietic stem cell transplantation in patients with multiple myeloma

Matevž Škerget, Barbara Skopec, Darja Žontar et al. · Radiology and Oncology · 2016 · 11 citations · Full text

Medicine, Hematology, Immunology +17

Filgrastim-alone versus pegylated filgrastim-alone for autologous peripheral blood stem cells mobilization in newly diagnosed multiple myeloma patients

Barbara Skopec, Matevž Škerget, Darja Žontar et al. · Wiener klinische Wochenschrift · 2017 · 11 citations

Medicine, Hematology, Oncology +12